A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

RecruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Bladder Cancer
Trial Locations (8)

14620

RECRUITING

University of Rochester Medical Center, Rochester

75390

RECRUITING

UT Southwestern Medical Center at Dallas, Dallas

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

90095

RECRUITING

UCLA Medical Center, Los Angeles

90822

RECRUITING

VA Long Beach Healthcare System, Long Beach

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

636-0802

RECRUITING

Nara Prefecture Seiwa Medical Center, Nara

Unknown

RECRUITING

Nara Medical University, Nara

All Listed Sponsors
collaborator

Nonagen Bioscience Corporation

INDUSTRY

collaborator

Nara Medical University

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of Rochester

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Texas, Southwestern Medical Center at Dallas

OTHER

collaborator

VA Long Beach Healthcare System

FED

collaborator

Nara Prefecture Seiwa Medical Center

UNKNOWN

collaborator

University of Hawaii Cancer Research Center

OTHER

collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

Hoag Memorial Hospital Presbyterian

OTHER

lead

Cedars-Sinai Medical Center

OTHER